Rethinking Diabetes: A Weekly Review
Malattie Metaboliche e Diabetologia
Type 2 Diabetes Mellitus. Recent Advances
What’s new in type 2 diabetes research? In this episode, we explore the latest studies on pathogenesis, early diagnosis, personalized treatment strategies, and connections with conditions like MASLD and neurodegenerative disorders. We also discuss youth-onset diabetes, intensive therapy approaches, digital interventions, and emerging pharmacological targets. A weekly roundup to stay updated on the science that matters.
Bibliography
- Strati M, Moustaki M, Psaltopoulou T, Vryonidou A, Paschou SA. Early onset type 2 diabetes mellitus: an update. Endocrine. 2024 Sep;85(3):965–78. doi:10.1007/s12020-024-03772-w. PMID: 38472622; PMCID: PMC11316703.
- Młynarska E, Czarnik W, Dzieża N, Jędraszak W, Majchrowicz G, Prusinowski F, et al. Type 2 Diabetes Mellitus: New Pathogenetic Mechanisms, Treatment and the Most Important Complications. Int J Mol Sci. 2025 Jan 27;26(3):1094. doi:10.3390/ijms26031094. PMID: 39940862; PMCID: PMC11817707.
- Lu X, Xie Q, Pan X, Zhang R, Zhang X, Peng G, et al. Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy. Signal Transduct Target Ther. 2024 Oct 2;9(1):262. doi:10.1038/s41392-024-01951-9. PMID: 39353925; PMCID: PMC11445387.
- Lee Jia Jia I, Zampetti S, Pozzilli P, Buzzetti R. Type 2 diabetes in children and adolescents: Challenges for treatment and potential solutions. Diabetes Res Clin Pract. 2024 Nov;217:111879. doi:10.1016/j.diabres.2024.111879. PMID: 39369858.
- Liu L, Ke W, Li H, Li F, Fan G, Kuang J, et al. Intense simplified strategy for newly diagnosed type 2 diabetes in patients with severe hyperglycaemia: multicentre, open label, randomised trial. BMJ. 2024 Oct 15;387:e080122. doi:10.1136/bmj-2024-080122. PMID: 39406449; PMCID: PMC11474422.
- Titmuss A, Korula S, Wicklow B, Nadeau KJ. Youth-onset Type 2 Diabetes: An Overview of Pathophysiology, Prognosis, Prevention and Management. Curr Diab Rep. 2024 Aug;24(8):183–95. doi:10.1007/s11892-024-01546-2. PMID: 38958831; PMCID: PMC11269415.
- Baduini IR, Castro Vildosola JE, Kavehmoghaddam S, Kiliç F, Nadeem SA, Nizama JJ, et al. Type 2 diabetes mellitus and neurodegenerative disorders: The mitochondrial connection. Pharmacol Res. 2024 Nov;209:107439. doi:10.1016/j.phrs.2024.107439. PMID: 39357690.
- Kerr D, Ahn D, Waki K, Wang J, Breznen B, Klonoff DC. Digital Interventions for Self-Management of Type 2 Diabetes Mellitus: Systematic Literature Review and Meta-Analysis. J Med Internet Res. 2024 Jul 22;26:e55757. doi:10.2196/55757. PMID: 39037772; PMCID: PMC11301119.
- Ferdous SE, Ferrell JM. Pathophysiological Relationship between Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Therapeutic Approaches. Int J Mol Sci. 2024 Aug 10;25(16):8731. doi:10.3390/ijms25168731. PMID: 39201418; PMCID: PMC11354927.
- Liu Y, Chen Y, Ma J, Lin J, Liu C, Li X, et al. Dapagliflozin plus calorie restriction for remission of type 2 diabetes: multicentre, double blind, randomised, placebo controlled trial. BMJ. 2025 Jan 22;388:e081820. doi:10.1136/bmj-2024-081820. PMID: 39843169; PMCID: PMC11752448.
